A carregar...
Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy
PURPOSE: Radiation dose escalation for prostate cancer improves biochemical control but is limited by toxicity. Magnetic resonance spectroscopic imaging (MRSI) can define dominant intraprostatic lesions (DIL). This phase I study evaluated dose escalation to MRSI-defined DIL using high-dose-rate (HDR...
Na minha lista:
| Publicado no: | J Contemp Brachytherapy |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Termedia Publishing House
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6052382/ https://ncbi.nlm.nih.gov/pubmed/30038638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2018.76881 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|